|
|
|
| KDM2B Expression Association with Gastric Cancer Recurrence |
| YIN Jun, ZHAO Ye-jian |
| Xiangcheng District Peoples Hospital, Suzhou, Jiangsu Province,215000 |
|
|
|
|
Abstract 【Objective】To investigate the relationship of Lysine (K)-specific demethylase 2B (KDM2B) expression with gastric cancer recurrence. 【Methods】Three hundred gastric cancer patients who received surgical treatment in our hospital were included in this study. The expression of KDM2B in gastric cancer tissues was detected and follow-up was conducted to determine the recurrence. Kaplan-Meier and log-rank test were used for univariate analysis, and significant factors in univariate analysis were introduced into Cox regression model. 【Results】According to TNM staging, among the 300 patients selected, 75 cases were categorized into stage Ⅰ, 63 cases were in stage Ⅱ, and 123 cases were in stage Ⅲ. Follow-up was completed in 278 patients, While 22 cases were lost to follow-up. The follow-up rate was 92.7%. KDM2B positive expression was shown in 123 patients (41%) . Recurrence and metastasis occurred in 142 patients. Univariate analysis showed that larger tumors, higher T stage, higher N stage, later TNM stage and positive KDM2B expression increased the risk of recurrence in patients with gastric cancer after surgery. Cox regression analysis showed that, compared to patients with negative KDM2B expression, patients with positive KDM2B expression increased risk of gastric cancer recurrence by 98% [HR:1.98;95%CI: 1.23-3.32]. 【Conclusion】Positive KDM2B expression increases the risk of postoperative recurrence in patients with gastric cancer and patients with positive KDM2B expression have a worse prognosis.
|
|
Received: 11 June 2019
|
|
|
|
|
|
[1] Peike P,Lingqiang M,Shushu S,et al. Elevated Expression of Calpain-4 Predicts Poor Prognosis in Patients with Gastric Cancer after Gastrectomy[J].Int J Molecular Sci,2016, 17(10):1612.
[2] 周洲,高采平,邱春华等.下调CD44基因表达对人胃癌SGC7901细胞裸鼠移植瘤的抑制作用及其机制[J].国际消化病杂志,2017,37(3):172-176.
[3] Zhao E,Tang C,Jiang X,et al. Inhibition of cell proliferation and induction of autophagy by KDM2B/FBXL10 knockdown in gastric cancer cells[J].Cellular Signalling,2017, 36:222-229.
[4] Song S,Peng P,Tang Z,et al. Decreased expression of STING predicts poor prognosis in patients with gastric cancer[J].Sci Rep,2017, 7(11):839-858.
[5] Yu X,Wang J,Wu J,et al. A systematic study of the cellular metabolic regulation of Jhdm1b in tumor cells[J].Molecular Biosystems,2015, 11(7):1867-1875.
[6] Petrie BA,Schwartz SI,Saltmarsh GM,et al. Recent advances of histone modification in gastric cancer[J].J Cancer Res & Therapeutics,2014, 10 Suppl(8):240.
[7] He J,Nguyen AT,Zhang Y.KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia[J].Blood,2011, 117(14):3869-3880.
[8] Zhao X,Wang X,Li Q,et al. FBXL10 contributes to the development of diffuse large B-cell lymphoma by epigenetically enhancing ERK1/2 signaling pathway[J].Cell Death & Disease,2018, 9(2):46. |
|
|
|
2020, Vol. 37 
